NCT02905513 is a NA clinical trial of Contraceptive app instant messages in Contraception, sponsored by London School of Hygiene and Tropical Medicine.

Who is sponsoring NCT02905513?

NCT02905513 is sponsored by London School of Hygiene and Tropical Medicine.

What drugs are being tested in NCT02905513?

Interventions in NCT02905513: Contraceptive app instant messages, Mobile phone app.

What condition does NCT02905513 study?

NCT02905513 studies Contraception.

Is NCT02905513 still recruiting?

NCT02905513 is currently completed. Last updated 7 February 2018.

Last reviewed 2018-02-07 · How we verify

NCT02905513

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Intervention Delivered by App Instant Messaging to Increase the Acceptability of Effective Contraception Among Young People in Tajikistan

Completed NA Last updated 7 February 2018

What this trial tests

NA trial testing Contraceptive app instant messages in Contraception in 580 participants. Completed in 30 November 2017.

Timeline

16 November 2016

Primary endpoint
31 July 2017

30 November 2017

Quick facts

Lead sponsor	London School of Hygiene and Tropical Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	580
Start date	16 November 2016
Primary completion	31 July 2017
Estimated completion	30 November 2017
Sites	1 location across Tajikistan

Drugs / interventions tested

Contraceptive app instant messages
Mobile phone app

Conditions studied

Contraception — all drugs for Contraception →

Sponsor

London School of Hygiene and Tropical Medicine

Who can join

Adults 16 to 24, any sex, with Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on the acceptability of effective contraception in Tajikistan. Woman and men aged 16-24 will be randomised to have access to the Tajik Family Planning Alliance's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 months.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A randomized controlled trial of an intervention delivered by mobile phone app instant messaging to increase the acceptability of effective contraception among young people in Tajikistan.
McCarthy O, Ahamed I, Kulaeva F, Tokhirov R, et al · · 2018 · cited 27× · PMID 29433506 · DOI 10.1186/s12978-018-0473-z
Mobile phone-based interventions for improving contraception use.
Perinpanathan T, Maiya S, van Velthoven MHH, Nguyen AT, et al · · 2023 · cited 6× · PMID 37458240 · DOI 10.1002/14651858.cd011159.pub3
A randomised controlled trial of an intervention delivered by app instant messaging to increase the acceptability of effective contraception among young people in Tajikistan: study protocol.
McCarthy O, Leurent B, Edwards P, Tokhirov R, et al · · 2017 · cited 6× · PMID 28939582 · DOI 10.1136/bmjopen-2017-017606

Verify or expand the search:

Other recruiting trials for Contraception

Currently open trials in the same condition.

NCT07365904 — Investigating Ovulation Inhibition for Use as a Contraceptive · Phase 2 · recruiting
NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
NCT06823037 — Hormonal Contraception Access Through Pharmacist Prescribing Implementation · NA · recruiting
NCT07326007 — Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women W · NA · recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting

Other London School of Hygiene and Tropical Medicine trials

Trials by the same sponsor.

NCT06921213 — Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis · Phase 2 · not yet recruiting
NCT06923592 — Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar · Phase 3 · recruiting
NCT06833736 — A Health App Using Recipes and Education Components to Facilitate Sustainable and Healthier Diets. · NA · completed
NCT06166498 — Parasite Clearance and Protection From Infection (PCPI) in Zambia · Phase 3 · completed
NCT06173206 — Parasite Clearance and Protection From Infection (PCPI) in Cameroon · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02905513 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London School of Hygiene and Tropical Medicine
Last refreshed: 7 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02905513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing